Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 821–840 of 17,529 recalls

February 7, 2025· Aspen Biopharma Labs Pvt., Ltd.

Recalled Item: Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 7, 2025· Aspen Biopharma Labs Pvt., Ltd.

Recalled Item: Voriconazole Container Description: voriconazole The product packed in white...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 6, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Morphine Sulfate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 6, 2025· Padagis US LLC

Recalled Item: Estradiol Gel

The Issue: Defective Container: Some packets may not be fully

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
February 4, 2025· AvKARE

Recalled Item: Silodosin Capsules

The Issue: Subpotent Drug: Out of Specification (OOS) result for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 31, 2025· Direct Rx

Recalled Item: CIPROFLOXACIN OPHTH SOLUTION

The Issue: Defective Container: Unable to get the solution out

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 31, 2025· Fagron Compounding Services

Recalled Item: fentaNYL Citrate In Sodium Chloride 1600mcg/100mL (16 mcg per mL) CII

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
January 31, 2025· Alvogen, Inc

Recalled Item: Fentanyl Transdermal System CII

The Issue: Defective delivery system - patches could be multi-stacked,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
January 30, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Potassium Chloride Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund